Advertisement
Singapore markets open in 8 hours 47 minutes

  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     

  • S&P 500

    5,017.13
    -54.50 (-1.07%)
     

  • Dow

    37,901.57
    -559.35 (-1.45%)
     

  • Nasdaq

    15,475.42
    -237.33 (-1.51%)
     

  • Bitcoin USD

    64,078.28
    -685.33 (-1.06%)
     

  • CMC Crypto 200

    1,386.49
    +3.91 (+0.28%)
     

  • FTSE 100

    8,078.86
    +38.48 (+0.48%)
     

  • Gold

    2,342.40
    +4.00 (+0.17%)
     

  • Crude Oil

    82.50
    -0.31 (-0.37%)
     

  • 10-Yr Bond

    4.7040
    +0.0520 (+1.12%)
     

  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     

  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     

  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Why Adaptimmune Therapeutics Stock Is Glowing Green Today

George Budwell, The Motley Fool
·2-min read
Why Adaptimmune Therapeutics Stock Is Glowing Green Today

Shares of the anti-cancer cell therapy company Adaptimmune Therapeutics (NASDAQ: ADAP) are having an unusually strong showing today. Ahead of the opening bell, Adaptimmune released both its third-quarter earnings and a clinical program update for its MAGE-A4 franchise. In an exploratory study of patients with various solid tumors, the company's modified T-cell therapy, known as ADP-A2M4CD8, reportedly produced an overall response rate of 43% in patients with advanced ovarian cancer.

Continue reading